Life Science REIT Statistics

Total Valuation

LON:LABS has a market cap or net worth of GBP 150.50 million. The enterprise value is 264.79 million.

Market Cap	150.50M
Enterprise Value	264.79M

Important Dates

The next estimated earnings date is Thursday, June 26, 2025.

Earnings Date	Jun 26, 2025
Ex-Dividend Date	Oct 3, 2024

Share Statistics

LON:LABS has 350.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	350.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.80%
Owned by Institutions (%)	117.82%
Float	315.95M

Valuation Ratios

Price/FFO Ratio	n/a
Price/AFFO Ratio	n/a
PE Ratio	n/a
Forward PE	35.83
PS Ratio	7.41
PB Ratio	0.57
P/TBV Ratio	0.57
P/FCF Ratio	n/a
P/OCF Ratio	11.65
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-18.94
EV / Sales	13.04
EV / EBITDA	n/a
EV / EBIT	27.62
EV / FCF	-41.64

Financial Position

The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.47.

Current Ratio	0.98
Quick Ratio	0.89
Debt / Equity	0.47
Debt / EBITDA	n/a
Debt / FCF	-19.22
Interest Coverage	0.92

Financial Efficiency

Return on equity (ROE) is -5.11% and return on invested capital (ROIC) is 1.54%.

Return on Equity (ROE)	-5.11%
Return on Assets (ROA)	1.48%
Return on Invested Capital (ROIC)	1.54%
Return on Capital Employed (ROCE)	2.47%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.04% in the last 52 weeks. The beta is -0.08, so LON:LABS's price volatility has been lower than the market average.

Beta (5Y)	-0.08
52-Week Price Change	+8.04%
50-Day Moving Average	41.55
200-Day Moving Average	37.74
Relative Strength Index (RSI)	49.07
Average Volume (20 Days)	592,294

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:LABS had revenue of GBP 20.31 million and -13.98 million in losses. Loss per share was -0.04.

Revenue	20.31M
Gross Profit	14.42M
Operating Income	9.59M
Pretax Income	-13.98M
Net Income	-13.98M
EBITDA	n/a
EBIT	9.59M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 7.95 million in cash and 122.24 million in debt, giving a net cash position of -114.29 million or -0.33 per share.

Cash & Cash Equivalents	7.95M
Total Debt	122.24M
Net Cash	-114.29M
Net Cash Per Share	-0.33
Equity (Book Value)	262.77M
Book Value Per Share	0.75
Working Capital	-214,000

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.92 million and capital expenditures -19.28 million, giving a free cash flow of -6.36 million.

Operating Cash Flow	12.92M
Capital Expenditures	-19.28M
Free Cash Flow	-6.36M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 71.03%, with operating and profit margins of 47.20% and -68.83%.

Gross Margin	71.03%
Operating Margin	47.20%
Pretax Margin	-68.83%
Profit Margin	-68.83%
EBITDA Margin	n/a
EBIT Margin	47.20%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 4.59%.

Dividend Per Share	0.02
Dividend Yield	4.59%
Dividend Growth (YoY)	-50.00%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	4.63%
Earnings Yield	-9.29%
FCF Yield	-4.23%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a